EUVIMEDEUVIMED entdecken
Open Access

Interest in I-PrEP and Willingness to Participate in Clinical Trials Among Men and Transfeminine Persons Who have Sex with Men in Sub-Saharan Africa: Quantitative and Qualitative Findings from HPTN 075

Theodorus G M Sandfort, Philip Kreniske, Calvin Mbeda, Doerieyah Reynolds, Gugulethu Tshabalala, Blessings Madiwati, Arthur Ogendo, Karen Dominquez, Ravindre Panchia, Daniel Gondwe, Erica L Hamilton, Xu Guo und 1 weitere

AIDS and Behavior · 2024

DOI: 10.1007/s10461-024-04334-x ↗

Kurz gefasst

Fachartikel in der Zeitschrift AIDS and Behavior, 2024. Verfasst von Theodorus G M Sandfort und 12 weiteren Autor:innen. Beteiligte Einrichtung: HIV Center for Clinical and Behavioral Studies, Department of Psychiatry, New York State Psychiatric Institute and Columbia University, 1051 Riversid…. Hauptthemen laut MEDLINE: HIV Infections, Homosexuality, Male, Qualitative Research, Pre-Exposure Prophylaxis. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIMH NIH HHS, National Institute of Allergy and Infectious Diseases, National Institute of Mental Health and Neurosciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study explored interest in injectable PrEP (I-PrEP) and willingness to participate in clinical trials testing new biomedical HIV prevention strategies among men and transfeminine persons who have sex with men (MSM & TGP), using data collected in the HIV Prevention Trials Network (HPTN) 075 study, which took place at sites in Kenya, Malawi, and South Africa. Data result from a survey among 267 18-44 years old HIV negative participants, complemented with semi-structured interviews with 80 purposively recruited persons. Correlations coefficients were calculated to identify demographic and psychosocial factors associated with interest in I-PrEP. Qualitative interviews were analyzed using concept-driven and subsequent data-driven coding. Most surveyed participants expressed an interest in I-PrEP. Quantitatively, only being interested in other HIV prevention measures was associated with interest in I-PrEP. Qualitatively, most participants preferred I-PrEP to O-PrEP and remained interested in I-PrEP despite barriers such as the somewhat invasive nature of the procedure and potential side effects of I-PrEP. Interest in I-PrEP was driven by the possibility of avoiding sexual or HIV stigma. Access to healthcare and altruism-such as assisting in the development of new HIV prevention methods-positively impacted willingness to participate in clinical trials. With I-PrEP favored by most participants, it is potentially a critical tool to prevent HIV infection among MSM & TGP in sub-Saharan Africa, with the mitigation of stigma as a major advance. Recruitment of MSM & TGP in biobehavioral clinical trials seems feasible, with altruistic reasons and receiving I-PrEP and free medical care as major motivators. RESUMEN: Este estudio exploró el interés en la PrEP inyectable (I-PrEP) y la voluntad de participar en ensayos clínicos que prueban nuevas estrategias biomédicas de prevención del VIH entre hombres y personas transfemeninas que tienen sexo con hombres (HSH y TGP), utilizando datos recopilados en la Red de Ensayos de Prevención del VIH. (HPTN) 075, que se llevó a cabo en sitios de Kenia, Malawi y Sudáfrica. Los datos son el resultado de una encuesta entre 267 participantes VIH negativos de entre 18 y 44 años, complementada con entrevistas semiestructuradas con 80 personas reclutadas intencionalmente. Se calcularon coeficientes de correlación para identificar factores demográficos y psicosociales asociados con el interés en la I-PrEP. Las entrevistas cualitativas se analizaron mediante codificación basada en conceptos y, posteriormente, basada en datos. La mayoría de los participantes encuestados expresaron interés en la I-PrEP. Cuantitativamente, sólo estar interesado en otras medidas de prevención del VIH se asoció con el interés en la I-PrEP. Cualitativamente, la mayoría de los participantes prefirieron la I-PrEP a la O-PrEP y siguieron interesados en la I-PrEP a pesar de barreras como la naturaleza algo invasiva del procedimiento y los posibles efectos secundarios de la I-PrEP. El interés en la I-PrEP fue impulsado por la posibilidad de evitar el estigma sexual o del VIH. El acceso a la atención sanitaria y el altruismo (como la asistencia en el desarrollo de nuevos métodos de prevención del VIH) tuvieron un impacto positivo en la voluntad de participar en ensayos clínicos. Dado que la mayoría de los participantes prefieren la I-PrEP, es potencialmente una herramienta crítica para prevenir la infección por VIH entre HSH y TGP en el África subsahariana, con la mitigación del estigma como un avance importante. El reclutamiento de HSH y TGP en ensayos clínicos bioconductuales parece factible, con razones altruistas y recibir I-PrEP y atención médica gratuita como principales motivadores.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HIV InfectionsHomosexuality, MaleQualitative ResearchPre-Exposure ProphylaxisPatient Acceptance of Health CareHumansMaleAdultYoung AdultAdolescentAfrica South of the SaharaAnti-HIV AgentsTransgender PersonsInterviews as TopicSurveys and QuestionnairesSexual and Gender MinoritiesClinical Trials as TopicSocial StigmaFemaleKenya

Stichwörter der Autor:innen

Men who have sex with menPre-exposure prophylaxis (PrEP)StigmaSub-Saharan AfricaTransfeminine persons

Substanzen

Anti-HIV Agents

Autor:innen und Institutionen

  • HIV Center for Clinical and Behavioral Studies, Department of Psychiatry, New York State Psychiatric Institute and Columbia University, 1051 Riverside Drive, Unit 15, New York, NY, 10032, USA. tgs2001@cumc.columbia.edu.
  • Community Health and Social Sciences Department, Graduate School of Public Health and Health Policy, City University of New York (CUNY), New York, USA.
  • Kenya Medical Research Institute (KEMRI) CDC, Kisumu, Kenya.
  • Desmond Tutu HIV Centre, Cape Town, South Africa.
  • Perinatal HIV Research Unit, University of the Witwatersrand, Soweto, South Africa.
  • College of Medicine-Johns Hopkins Research Project, Blantyre, Malawi.

Förderung

  • NIMH NIH HHS
  • National Institute of Allergy and Infectious Diseases
  • National Institute of Mental Health and Neurosciences
  • NIAID NIH HHS

Zitieren

APA

Sandfort, T. G. M., Kreniske, P., Mbeda, C., Reynolds, D., Tshabalala, G., Madiwati, B., Ogendo, A., Dominquez, K., Panchia, R., Gondwe, D., Hamilton, E. L., Guo, X., & Cummings, V. (2024). Interest in I-PrEP and Willingness to Participate in Clinical Trials Among Men and Transfeminine Persons Who have Sex with Men in Sub-Saharan Africa: Quantitative and Qualitative Findings from HPTN 075. AIDS and Behavior. https://doi.org/10.1007/s10461-024-04334-x

Vancouver

Sandfort TGM, Kreniske P, Mbeda C, Reynolds D, Tshabalala G, Madiwati B, et al. Interest in I-PrEP and Willingness to Participate in Clinical Trials Among Men and Transfeminine Persons Who have Sex with Men in Sub-Saharan Africa: Quantitative and Qualitative Findings from HPTN 075. AIDS and Behavior. 2024. doi:10.1007/s10461-024-04334-x

BibTeX
@article{Sandfort2024,
  author = {Sandfort, Theodorus G M and Kreniske, Philip and Mbeda, Calvin and Reynolds, Doerieyah and Tshabalala, Gugulethu and Madiwati, Blessings and Ogendo, Arthur and Dominquez, Karen and Panchia, Ravindre and Gondwe, Daniel and Hamilton, Erica L and Guo, Xu and Cummings, Vanessa},
  title = {Interest in I-PrEP and Willingness to Participate in Clinical Trials Among Men and Transfeminine Persons Who have Sex with Men in Sub-Saharan Africa: Quantitative and Qualitative Findings from HPTN 075},
  journal = {AIDS and Behavior},
  year = {2024},
  doi = {10.1007/s10461-024-04334-x}
}
Kostenlos starten →